Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. SPY
5. FDX
6. IBM
7. MU
8. AWK
9. ACN
10. USO

Go back to Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
(NASDAQ: ALLR) Delayed: 1.32 -0.04 (2.94%)
Previous Close $1.36    52 Week High $ 
Open $1.32    52 Week Low $ 
Day High $1.36    P/E N/A 
Day Low $1.30    EPS $ 
Volume 80,081       

(NASDAQ: ALLR) Delayed: 1.32 -0.04 (2.94%)
Previous Close $1.36    52 Week High $ 
Open $1.32    52 Week Low $ 
Day High $1.36    P/E N/A 
Day Low $1.30    EPS $ 
Volume 80,081